{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:13:41Z","timestamp":1781892821277,"version":"3.54.5"},"reference-count":108,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.cardfail.2014.05.007","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T16:54:17Z","timestamp":1401296057000},"page":"611-622","source":"Crossref","is-referenced-by-count":41,"title":["Loop Diuretic Resistance in Heart Failure: Resistance Etiology\u2013Based Strategies to Restoring Diuretic Efficacy"],"prefix":"10.1016","volume":"20","author":[{"given":"Zachary L.","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9458-0154","authenticated-orcid":false,"given":"Daniel J.","family":"Lenihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2014.05.007_bib1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ahj.2007.03.012","article-title":"Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"153","author":"Fonarow","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2014.05.007_bib2","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2014.05.007_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2014.05.007_bib6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2014.05.007_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","article-title":"Diuretic resistance predicts mortality in patients with advanced heart failure","volume":"144","author":"Neuberg","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2014.05.007_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 comprehensive heart failure practice guideline","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2014.05.007_bib9","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.jacc.2013.05.020","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cardfail.2003.10.006","article-title":"Searching for evidence: Refractory questions in advanced heart failure","volume":"10","author":"Shah","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2014.05.007_bib11","series-title":"Torsemide [package insert]","year":"2003"},{"key":"10.1016\/j.cardfail.2014.05.007_bib12","series-title":"Bumetanide [package insert]","year":"2010"},{"key":"10.1016\/j.cardfail.2014.05.007_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1365-2125.1996.00494.x","article-title":"Effect of food on the absorption of frusemide and bumetanide in man","volume":"42","author":"McCrindle","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF00615967","article-title":"Reduced bioavailability and effect of furosemide given with food","volume":"29","author":"Beermann","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1592\/phco.24.6.630.34736","article-title":"Food: an unrecognized source of loop diuretic resistance","volume":"24","author":"Bard","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cardfail.2014.05.007_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7326\/0003-4819-102-3-314","article-title":"Furosemide absorption altered in decompensated congestive heart failure","volume":"102","author":"Vasko","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0002-9343(98)00111-9","article-title":"The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure","volume":"104","author":"Gottlieb","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib19","series-title":"Furosemide [package insert]","year":"2012"},{"key":"10.1016\/j.cardfail.2014.05.007_bib20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1681\/ASN.V133798","article-title":"New insights into diuretic use in patients with chronic renal disease","volume":"13","author":"Wilcox","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib21","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJM197305242882102","article-title":"Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction","volume":"288","author":"Dikshit","year":"1973","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.cardfail.2014.05.007_bib22","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1111\/j.1751-7133.2010.00172.x","article-title":"Diuretic management in heart failure","volume":"16","author":"Felker","year":"2010","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cardfail.2014.05.007_bib23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/01.RES.53.5.630","article-title":"Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins","volume":"53","author":"Johnston","year":"1983","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2014.05.007_bib24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0022-3565(25)27516-4","article-title":"Effects of several saluretic-diuretic agents on renal hemodynamics","volume":"154","author":"Hook","year":"1966","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cardfail.2014.05.007_bib25","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.jacc.2011.10.910","article-title":"Diuretics and ultrafiltration in acute decompensated heart failure","volume":"59","author":"Felker","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","article-title":"Diuretic therapy and resistance in congestive heart failure","volume":"96","author":"Ellison","year":"2001","journal-title":"Cardiology"},{"key":"10.1016\/j.cardfail.2014.05.007_bib27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/CIRCULATIONAHA.109.192628","article-title":"State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association","volume":"120","author":"Riegel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.05.007_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archinte.164.7.709","article-title":"Keeping your patient with heart failure safe: a review of potentially dangerous medications","volume":"164","author":"Amabile","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejcnurse.2007.04.001","article-title":"Nurse educational activity on non-prescription therapies in patients with chronic heart failure","volume":"6","author":"dal Corso","year":"2007","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.cardfail.2014.05.007_bib30","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/hrt.2005.082388","article-title":"Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population","volume":"92","author":"Huerta","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.cardfail.2014.05.007_bib31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.160.6.777","article-title":"Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem","volume":"160","author":"Page","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.EDE.0000034633.74133.C3","article-title":"Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure","volume":"14","author":"Garcia Rodriguez","year":"2003","journal-title":"Epidemiology"},{"key":"10.1016\/j.cardfail.2014.05.007_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3565(25)21448-3","article-title":"Indomethacin-furosemide interaction: the importance of renal blood flow","volume":"226","author":"Nies","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"issue":"5 Pt 2","key":"10.1016\/j.cardfail.2014.05.007_bib34","first-page":"F698","article-title":"Prostaglandin inhibitors alter loop segment chloride uptake during furosemide diuresis","volume":"248","author":"Kirchner","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib35","first-page":"F666","article-title":"Furosemide action on collecting ducts: effect of prostaglandin synthesis inhibition","volume":"244","author":"Wilson","year":"1983","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-3565(25)23494-2","article-title":"Role of medullary plasma flow in the attenuated furosemide response in indomethacin-treated rats","volume":"249","author":"Kirchner","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cardfail.2014.05.007_bib37","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.05.007_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/clpt.1988.186","article-title":"Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with congestive heart failure","volume":"44","author":"Cook","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cardfail.2014.05.007_bib39","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0009-9236(95)90222-8","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure","volume":"57","author":"Vargo","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cardfail.2014.05.007_bib40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ki.1982.149","article-title":"Absorption and disposition of furosemide in congestive heart failure","volume":"22","author":"Brater","year":"1982","journal-title":"Kidney Int"},{"key":"10.1016\/j.cardfail.2014.05.007_bib41","unstructured":"Food and Drug Administration. Orange book preface. 1984. Available at: http:\/\/www.fda.gov\/drugs\/developmentapprovalprocess\/ucm079068.htm."},{"key":"10.1016\/j.cardfail.2014.05.007_bib42","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/j.1552-4604.1998.tb04810.x","article-title":"Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure","volume":"38","author":"Bleske","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib43","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(64)92608-X","article-title":"The diuretic response to frusemide","volume":"2","author":"Robson","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2014.05.007_bib44","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-114-10-886","article-title":"The physiologic basis of diuretic synergism: its role in treating diuretic resistance","volume":"114","author":"Ellison","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib45","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.1989.246","article-title":"Mechanism of impaired natriuretic response to furosemide during prolonged therapy","volume":"36","author":"Loon","year":"1989","journal-title":"Kidney Int"},{"issue":"6 Pt 2","key":"10.1016\/j.cardfail.2014.05.007_bib46","first-page":"F1256","article-title":"Adaptation of distal tubule and collecting duct to increased sodium delivery. I. Ultrastructure","volume":"255","author":"Kaissling","year":"1988","journal-title":"Am J Physiol"},{"issue":"6 Pt 2","key":"10.1016\/j.cardfail.2014.05.007_bib47","first-page":"F1269","article-title":"Adaptation of distal tubule and collecting duct to increased Na delivery. II. Na+ and K+ transport","volume":"255","author":"Stanton","year":"1988","journal-title":"Am J Physiol"},{"issue":"1 Pt 2","key":"10.1016\/j.cardfail.2014.05.007_bib48","first-page":"F1","article-title":"Regulation of renal ion transport and cell growth by sodium","volume":"257","author":"Stanton","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib49","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib50","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00041552-200309000-00001","article-title":"Diuretic use in stage 5 chronic kidney disease and end-stage renal disease","volume":"12","author":"Sica","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.cardfail.2014.05.007_bib52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1527-5299.2003.01907.x","article-title":"Metolazone and its role in edema management","volume":"9","author":"Sica","year":"2003","journal-title":"Congest Heart Fail"},{"issue":"931","key":"10.1016\/j.cardfail.2014.05.007_bib53","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/pmj.79.931.268","article-title":"Mechanisms and management of diuretic resistance in congestive heart failure","volume":"79","author":"De Bruyne","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cardfail.2014.05.007_bib54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3565(24)38896-2","article-title":"Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1","volume":"295","author":"Uwai","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cardfail.2014.05.007_bib55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.1988.00380020030006","article-title":"High-dose furosemide in the treatment of refractory congestive heart failure","volume":"148","author":"Gerlag","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.rlu.0000113851.70154.2a","article-title":"Increasing the dose of furosemide in patients with azotemia and suspected obstruction","volume":"29","author":"Hunsche","year":"2004","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib57","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.05.007_bib58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000185059","article-title":"Pharmacokinetic and pharmacodynamic interactions between furosemide and hydrochlorothiazide in nephrotic patients","volume":"49","author":"Nakahama","year":"1988","journal-title":"Nephron"},{"key":"10.1016\/j.cardfail.2014.05.007_bib59","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ki.1991.228","article-title":"Binding inhibitors restore furosemide potency in tubule fluid containing albumin","volume":"40","author":"Kirchner","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.cardfail.2014.05.007_bib60","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0024-3205(80)90238-6","article-title":"Resistance of proteinuric rats to furosemide: urinary drug protein binding as a determinant of drug effect","volume":"26","author":"Green","year":"1980","journal-title":"Life Sci"},{"key":"10.1016\/j.cardfail.2014.05.007_bib61","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0022-3565(25)20166-5","article-title":"Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome","volume":"252","author":"Kirchner","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cardfail.2014.05.007_bib62","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1476-5381.1996.tb15755.x","article-title":"The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit","volume":"119","author":"Pichette","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib63","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/1074248412474347","article-title":"The effect of continuous infusion loop diuretics in patients with acute decompensated heart failure with hypoalbuminemia","volume":"18","author":"Bleske","year":"2013","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.cardfail.2014.05.007_bib64","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cardfail.2011.02.010","article-title":"Human serum albumin in the clinical syndrome of heart failure","volume":"17","author":"Arques","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2014.05.007_bib65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/phar.1241","article-title":"Baseline albumin is associated with worsening renal function in patients with acute decompensated heart failure receiving continuous infusion loop diuretics","volume":"33","author":"Clarke","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cardfail.2014.05.007_bib66","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/CIRCHEARTFAILURE.108.821785","article-title":"Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?","volume":"2","author":"Felker","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2014.05.007_bib67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0009-9236(96)90170-8","article-title":"Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration","volume":"60","author":"Wakelkamp","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cardfail.2014.05.007_bib68","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1681\/ASN.V3121878","article-title":"A volume-independent component to postdiuretic sodium retention in humans","volume":"3","author":"Almeshari","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib69","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-3565(25)21252-6","article-title":"Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling","volume":"233","author":"Hammarlund","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cardfail.2014.05.007_bib70","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jacc.2013.04.073","article-title":"Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF","volume":"62","author":"Gottlieb","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib71","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.107.737106","article-title":"Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action","volume":"117","author":"Elkayam","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.05.007_bib72","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/01.CCM.0000124871.58281.D1","article-title":"Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure","volume":"32","author":"Ungar","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib73","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cardfail.2010.07.246","article-title":"Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) trial","volume":"16","author":"Giamouzis","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2014.05.007_bib74","unstructured":"National Heart, Lung, and Blood Institute. Dopamine in Acute Decompensated Heart Failure II (DAD-HF II). Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01060293. Accessed September 17,\u00a02013."},{"key":"10.1016\/j.cardfail.2014.05.007_bib75","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijcard.2013.12.276","article-title":"Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial","volume":"172","author":"Triposkiadis","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib76","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial","volume":"310","author":"Chen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2014.05.007_bib77","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCHEARTFAILURE.113.000347","article-title":"Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial","volume":"6","author":"Chen","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2014.05.007_bib78","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.CCM.0000166876.41694.CA","article-title":"\u201cRenal dose\u201d dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery","volume":"33","author":"Argalious","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib79","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(00)03495-4","article-title":"Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group","volume":"356","author":"Bellomo","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2014.05.007_bib80","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/hrt.71.2.146","article-title":"Combination diuretic treatment in severe heart failure: a randomised controlled trial","volume":"71","author":"Channer","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.cardfail.2014.05.007_bib81","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00005344-199509000-00008","article-title":"Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure","volume":"26","author":"Knauf","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib82","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ki.1994.298","article-title":"Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure","volume":"46","author":"Fliser","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.cardfail.2014.05.007_bib83","series-title":"Metolazone [package insert]","year":"2004"},{"key":"10.1016\/j.cardfail.2014.05.007_bib84","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9149(96)00465-1","article-title":"Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])","volume":"78","author":"Pitt","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib85","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","article-title":"Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?","volume":"2","author":"Bansal","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2014.05.007_bib86","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"Randomized Aldactone Evaluation Study Investigators The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib87","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1681\/ASN.V1271335","article-title":"Loop diuretic infusion increases thiazide-sensitive Na(+)\/Cl(\u2212)-cotransporter abundance: role of aldosterone","volume":"12","author":"Abdallah","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib88","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(93)90241-4","article-title":"Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor","volume":"71","author":"van Vliet","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib89","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.jacc.2013.03.042","article-title":"Cardiohepatic interactions in heart failure: an overview and clinical implications","volume":"61","author":"Samsky","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1)","key":"10.1016\/j.cardfail.2014.05.007_bib90","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1007\/s10557-011-6303-y","article-title":"Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"25","author":"Matsuzaki","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.cardfail.2014.05.007_bib91","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","article-title":"Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.05.007_bib92","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cardfail.2011.08.005","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction","volume":"17","author":"Udelson","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2014.05.007_bib93","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2014.05.007_bib94","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cardfail.2013.04.001","article-title":"Clinical Course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan","volume":"19","author":"Hauptman","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2014.05.007_bib95","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cardfail.2011.12.009","article-title":"Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network","volume":"18","author":"Bart","year":"2012","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2014.05.007_bib96","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib97","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jacc.2012.01.077","article-title":"Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure","volume":"60","author":"Ronco","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib98","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: new perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.05.007_bib99","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib100","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jacc.2007.08.072","article-title":"Cardiorenal interactions: insights from the ESCAPE trial","volume":"51","author":"Nohria","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.107.746933","article-title":"Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)","volume":"1","author":"Klein","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2014.05.007_bib102","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(88)91851-X","article-title":"Raised venous pressure: a direct cause of renal sodium retention in oedema?","volume":"1","author":"Firth","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2014.05.007_bib103","first-page":"F19","article-title":"Segmental analysis of sodium reabsorption during renal vein constriction","volume":"243","author":"Burnett","year":"1982","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib104","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.05.007_bib105","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2013.04.070","article-title":"Abdominal contributions to cardiorenal dysfunction in congestive heart failure","volume":"62","author":"Verbrugge","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib106","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2007.09.043","article-title":"Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?","volume":"51","author":"Mullens","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.007_bib107","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cardfail.2008.02.010","article-title":"Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure","volume":"14","author":"Mullens","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2014.05.007_bib108","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.jacc.2012.08.957","article-title":"Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure","volume":"60","author":"Patarroyo","year":"2012","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916414002115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916414002115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:40:22Z","timestamp":1746247222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916414002115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":108,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1071916414002115"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2014.05.007","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}